PL374817A1 - Pochodne chinazoliny - Google Patents
Pochodne chinazolinyInfo
- Publication number
- PL374817A1 PL374817A1 PL03374817A PL37481703A PL374817A1 PL 374817 A1 PL374817 A1 PL 374817A1 PL 03374817 A PL03374817 A PL 03374817A PL 37481703 A PL37481703 A PL 37481703A PL 374817 A1 PL374817 A1 PL 374817A1
- Authority
- PL
- Poland
- Prior art keywords
- quinazoline derivatives
- quinazoline
- derivatives
- Prior art date
Links
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02014904 | 2002-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL374817A1 true PL374817A1 (pl) | 2005-10-31 |
Family
ID=30011055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03374817A PL374817A1 (pl) | 2002-07-05 | 2003-06-27 | Pochodne chinazoliny |
Country Status (18)
Country | Link |
---|---|
US (1) | US7205309B2 (pl) |
EP (1) | EP1560816A1 (pl) |
JP (1) | JP2005535648A (pl) |
KR (1) | KR100647932B1 (pl) |
CN (1) | CN1665791A (pl) |
AR (1) | AR040389A1 (pl) |
AU (1) | AU2003281346B2 (pl) |
BR (1) | BR0312461A (pl) |
CA (1) | CA2489251A1 (pl) |
GT (1) | GT200300136A (pl) |
MX (1) | MXPA05000131A (pl) |
PA (1) | PA8576701A1 (pl) |
PE (1) | PE20040646A1 (pl) |
PL (1) | PL374817A1 (pl) |
RU (2) | RU2296757C2 (pl) |
TW (1) | TW200401642A (pl) |
UY (1) | UY27883A1 (pl) |
WO (1) | WO2004005265A1 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900226B2 (en) * | 2000-09-06 | 2005-05-31 | Hoffman-La Roche Inc. | Neuropeptide Y antagonists |
GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
GB0525068D0 (en) * | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
US9107040B2 (en) | 2010-09-29 | 2015-08-11 | Apple Inc. | Systems, methods, and computer readable media for sharing awareness information |
CN103204818B (zh) * | 2013-04-26 | 2015-04-15 | 清华大学 | 一种多取代喹唑啉衍生物的制备方法 |
CN104151255B (zh) * | 2014-07-22 | 2016-07-13 | 清华大学 | 一种多取代喹唑啉亚胺衍生物及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US3753981A (en) * | 1970-07-15 | 1973-08-21 | Squibb & Sons Inc | 4-amino-2-styrylquinazoline compounds |
US4035367A (en) | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
CA1328881C (en) | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
CA1270837A (en) | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
GB8910722D0 (en) * | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
CA2035972C (en) | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
CA2095213A1 (en) * | 1990-11-06 | 1992-05-07 | Jotham W. Coe | Quinazoline derivatives for enhancing antitumor activity |
US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
CA2148260A1 (en) * | 1993-09-10 | 1995-03-16 | Yasutaka Takase | Quinazoline cpompounds |
US5552411A (en) | 1995-05-26 | 1996-09-03 | Warner-Lambert Company | Sulfonylquinolines as central nervous system and cardiovascular agents |
US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
AU8748798A (en) * | 1997-08-22 | 1999-03-16 | Kyowa Hakko Kogyo Co. Ltd. | 4-aminoquinazoline derivatives |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
ATE293970T1 (de) | 1998-08-14 | 2005-05-15 | Hoffmann La Roche | Lipasehemmer enthaltende pharmazeutische zusammensetzungen |
CN1152680C (zh) | 1998-08-14 | 2004-06-09 | 霍夫曼-拉罗奇有限公司 | 含有脂酶抑制剂和壳聚糖的药物组合物 |
US6506762B1 (en) | 1999-09-30 | 2003-01-14 | Neurogen Corporation | Certain alkylene diamine-substituted heterocycles |
US6900226B2 (en) | 2000-09-06 | 2005-05-31 | Hoffman-La Roche Inc. | Neuropeptide Y antagonists |
DE10064105A1 (de) | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
DE60225274T2 (de) | 2001-05-21 | 2009-03-26 | F. Hoffmann-La Roche Ag | Chinolinderivate als liganden für den neuropeptid-y-rezeptor |
-
2003
- 2003-06-27 PL PL03374817A patent/PL374817A1/pl not_active Application Discontinuation
- 2003-06-27 EP EP03740372A patent/EP1560816A1/en not_active Withdrawn
- 2003-06-27 KR KR1020057000129A patent/KR100647932B1/ko not_active IP Right Cessation
- 2003-06-27 MX MXPA05000131A patent/MXPA05000131A/es not_active Application Discontinuation
- 2003-06-27 WO PCT/EP2003/006868 patent/WO2004005265A1/en active IP Right Grant
- 2003-06-27 RU RU2005102916/04A patent/RU2296757C2/ru not_active IP Right Cessation
- 2003-06-27 AU AU2003281346A patent/AU2003281346B2/en not_active Ceased
- 2003-06-27 JP JP2004518609A patent/JP2005535648A/ja active Pending
- 2003-06-27 CN CN038159341A patent/CN1665791A/zh active Pending
- 2003-06-27 BR BR0312461-4A patent/BR0312461A/pt not_active IP Right Cessation
- 2003-06-27 CA CA002489251A patent/CA2489251A1/en not_active Abandoned
- 2003-07-02 GT GT200300136A patent/GT200300136A/es unknown
- 2003-07-02 PE PE2003000671A patent/PE20040646A1/es not_active Application Discontinuation
- 2003-07-02 TW TW092118070A patent/TW200401642A/zh unknown
- 2003-07-02 PA PA20038576701A patent/PA8576701A1/es unknown
- 2003-07-03 US US10/613,782 patent/US7205309B2/en not_active Expired - Fee Related
- 2003-07-03 AR ARP030102414A patent/AR040389A1/es not_active Application Discontinuation
- 2003-07-04 UY UY27883A patent/UY27883A1/es not_active Application Discontinuation
-
2006
- 2006-09-19 RU RU2006133451/04A patent/RU2006133451A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003281346A1 (en) | 2004-01-23 |
RU2296757C2 (ru) | 2007-04-10 |
TW200401642A (en) | 2004-02-01 |
WO2004005265A1 (en) | 2004-01-15 |
US20040029901A1 (en) | 2004-02-12 |
AU2003281346B2 (en) | 2007-04-05 |
PA8576701A1 (es) | 2004-03-10 |
GT200300136A (es) | 2004-03-15 |
EP1560816A1 (en) | 2005-08-10 |
US7205309B2 (en) | 2007-04-17 |
UY27883A1 (es) | 2003-12-31 |
PE20040646A1 (es) | 2004-09-18 |
KR20050018947A (ko) | 2005-02-28 |
CA2489251A1 (en) | 2004-01-15 |
AR040389A1 (es) | 2005-03-30 |
MXPA05000131A (es) | 2005-04-11 |
JP2005535648A (ja) | 2005-11-24 |
RU2006133451A (ru) | 2008-03-27 |
BR0312461A (pt) | 2005-04-26 |
KR100647932B1 (ko) | 2006-11-23 |
CN1665791A (zh) | 2005-09-07 |
RU2005102916A (ru) | 2006-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1111417A1 (en) | Quinazoline derivatives | |
GB0215823D0 (en) | Quinazoline derivatives | |
GB0322409D0 (en) | Quinazoline derivatives | |
IL174534A0 (en) | Quinazoline derivatives | |
HK1091479A1 (en) | Quinazoline derivatives | |
ZA200602264B (en) | Quinazoline derivatives | |
GB0321648D0 (en) | Quinazoline derivatives | |
IL175421A0 (en) | Quinazoline derivatives | |
AP1850A (en) | Spiroindolineplperidine derivatives | |
EG24050A (en) | Heterocylocarboxamide derivatives | |
HK1070367A1 (en) | Quinazoline compounds | |
IL174390A0 (en) | Quinazoline derivatives | |
EP1522540A4 (en) | AZAARENE DERIVATIVES | |
GB0330002D0 (en) | Quinazoline derivatives | |
PL377474A1 (pl) | Pochodne 3H-chinazolin-4-onu | |
ZA200603039B (en) | Quinazoline derivatives | |
GB2410025B (en) | Quinazolin-4-one derivatives | |
AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
PL374817A1 (pl) | Pochodne chinazoliny | |
EP1531854A4 (en) | O-DERIVATED NOCATHIACIN DERIVATIVES | |
GB0321620D0 (en) | Quinazoline derivatives | |
GB0213488D0 (en) | 2-Naphthamide derivatives | |
AU2003243397A8 (en) | Homo-camptothecin derivatives | |
GB0215825D0 (en) | Quinazoline derivatives | |
AU2003290279A1 (en) | Quinazoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |